ARYZTA (ARYN) Investor Update summary
Event summary combining transcript, slides, and related documents.
Investor Update summary
14 Dec, 2025Financial performance and guidance
EBITDA guidance reset to at least €300 million for 2025, reflecting slower-than-expected cost measures and challenging market conditions, compared to €320.9 million in 2024.
Organic growth guidance reiterated at low- to mid-single-digit for 2025, supported by pricing and volume.
Free cash flow for the year expected to be around €100 million, with accelerated cost and improvement measures.
New production lines in Switzerland and Germany are ramping up as planned, not loss-making; a major project in Perth is on track for Q1 2026.
Margin recovery to 15% remains a mid-term goal, but near-term margin pressure is acknowledged.
Management and governance update
CEO Michael Schai steps down immediately after a mutual decision with the Board; Urs Jordi, Chairman, is appointed interim CEO.
Board maintains strong oversight and governance, with active committees and experienced directors.
Focus is on business performance and addressing current challenges, with future leadership structure to be discussed later.
The Board expresses gratitude to Michael Schai and emphasizes unity in the leadership transition.
Strategic priorities and market environment
Emphasis on accelerating cost measures and operational improvements in response to inflation and competitive pressures.
Industry remains highly competitive, with price pressure and aggressive tendering considered normal.
Organic growth and business fitness prioritized over acquisitions; industry consolidation monitored but not a current focus.
Return of capital to shareholders will follow repayment of hybrid instruments and maintaining a 30% equity ratio.
Company aims to be a strong partner to customers amid evolving market realities.
Latest events from ARYZTA
- Revenue, EBITDA, and cash flow rose; capital return policy and bond repurchase set for 2026.ARYN
Q4 20252 Mar 2026 - EBITDA margin rose to 14.2% on €1,055.2m revenue, with leverage down to 2.9x.ARYN
H1 20241 Feb 2026 - FY2025 targets exceeded, with strong EBITDA, cash flow, and major investment in Portugal.ARYN
Q4 2025 TU22 Jan 2026 - Midterm targets met early, with higher margins, strong cash flow, and double-digit EPS growth.ARYN
H2 202410 Dec 2025 - Revenue and EPS rose, with margin pressured by inflation but guidance reaffirmed.ARYN
H1 202523 Nov 2025 - Targets above-market growth and >15% EBITDA margin by 2028 through innovation and efficiency.ARYN
CMD 202517 Nov 2025 - Q3 organic growth 0.8%, YTD 2.1%, FY25: €300m EBITDA, €100m free cash flow, cost optimisation.ARYN
Q3 2025 TU20 Oct 2025 - Innovation-led growth, margin expansion, and strong cash flow drive ARYZTA's robust performance.ARYN
Investor Presentation13 Jun 2025 - Q3 organic growth rebounded to 2.0%, with strong volumes and cost-saving initiatives underway.ARYN
Q3 2024 TU13 Jun 2025